Evidence map›Paper›PMID 40455753›Full record

ArticlePLoS neglected tropical diseases2025

Adaptive integrated intervention approaches for schistosomiasis elimination in Pemba: A 4-year intervention study and focus on hotspots.

Lydia Trippler, Said Mohammed Ali, Mohammed Nassor Ali, Ulfat Amour Mohammed, Khamis Rashid Suleiman, Naomi Chi Ndum, Saleh Juma, Shaali Makame Ame, Fatma Kabole, Jan Hattendorf and 1 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lydia TripplerSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Said Mohammed AliPublic Health Laboratory - Ivo de Carneri, Chake Chake, Pemba, United Republic of Tanzania.
Mohammed Nassor AliPublic Health Laboratory - Ivo de Carneri, Chake Chake, Pemba, United Republic of Tanzania.
Ulfat Amour MohammedPublic Health Laboratory - Ivo de Carneri, Chake Chake, Pemba, United Republic of Tanzania.
Khamis Rashid SuleimanPublic Health Laboratory - Ivo de Carneri, Chake Chake, Pemba, United Republic of Tanzania.
Naomi Chi NdumSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Saleh JumaNeglected Diseases Program, Zanzibar Ministry of Health, Chake Chake, Pemba, United Republic of Tanzania.
Shaali Makame AmeNeglected Diseases Program, Zanzibar Ministry of Health, Zanzibar, Unguja, United Republic of Tanzania.
Fatma KaboleNeglected Diseases Program, Zanzibar Ministry of Health, Zanzibar, Unguja, United Republic of Tanzania.
Jan HattendorfSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Stefanie KnoppSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0001-5707-7963

Funding

Swiss National Science Foundation (SNSF; Bern, Switzerland)
6 · The paper itself

Abstract

backgroundSchistosomiasis is a disease of poverty. Integrated interventions are recommended for its elimination. Despite major prevalence reductions over the past decades, hotspot areas with persistent or recurring moderate or high prevalence remain. We aimed to assess the contribution of multidisciplinary interventions that were adapted to the local micro-epidemiology for schistosomiasis elimination in Pemba, Tanzania, and to identify drivers for the occurrence of hotspot areas. METHODOLOGY: From 2020 to 2024, annual cross-sectional surveys were conducted in schools and communities in 20 implementation units (IUs) to assess the Schistosoma haematobium prevalence and monitor the impact of interventions. Based on the prevalence, the IUs were annually re-stratified into hotspot and low-prevalence IUs. In hotspots, mass drug administration in schools and communities, snail control and behavior change measures were implemented. Low-prevalence areas received surveillance-response interventions. With a random effects model, the association between S. haematobium infections and environmental and economic factors were assessed. Using risk layers based on the random effects model, hotspot areas were determined geographically. PRINCIPAL

findingsThe overall S. haematobium prevalence in the 20 IUs changed from 1.2% (26/2200, 95% Confidence Interval (CI): 0.5-1.9%) in 2021 to 1.0% (27/2752, 95% CI: 0.4-1.6%) in 2024 in schools, and from 0.8% (31/3885, 95% CI: 0.4-1.2%) in 2021 to 1.2% (43/3711, 95% CI: 0.3-2.0%) in 2024 in communities. Across the study period, 8 IUs were considered a hotspot. The number of hotspot IUs decreased from 5 in 2021, to 4 in 2022, to 3 in 2023 but increased again to 5 in 2024. Some of the hotspot IUs resurged once interventions were adapted to surveillance-response. S. haematobium infections were significantly associated with the standardized kernel density of water bodies with Bulinus presence (Odds Ratio (OR): 2.3; 95% CI: 1.6-3.4), a very low economic score (OR: 4.1; 95% CI: 1.7-9.9) and living far away from a road (OR: 4.7; 95% CI: 2.1-10.6).

conclusionAdaptive multidisciplinary interventions maintained the very low prevalence in Pemba but failed to interrupt S. haematobium transmission within 4 years. A comprehensive integrated intervention package contributed to reducing the number of hotspot IUs. However, some hotspots persisted also intense interventions or resurged once interventions were adapted to surveillance-response. To achieve complete elimination in Pemba and elsewhere, poverty needs to be reduced, and investments in global health equity, including the water sanitation and hygiene infrastructure, are essential.

trial registrationISRCTN, ISCRCTN91431493. Registered 11 February 2020, https://www.isrctn.com/ISRCTN91431493.

Indexed as

Disease EradicationSchistosomiasisSchistosomiasis haematobiaAdolescentAnimalsChildCross-Sectional StudiesFemaleHumansMaleMass Drug AdministrationPrevalenceSchistosoma haematobiumSchoolsSnailsTanzania

Identifiers

PMID40455753
PMCPMC12129218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.